Selinexor enhances the sensitivity of hepatocellular carcinoma cells to sorafenib by regulating the BAX/Bcl-2/PUMA apoptotic pathway and the XPO1/p27 cell cycle pathway. [PDF]
Du S +8 more
europepmc +1 more source
Impaired nucleocytoplasmic transport in SOD1-mediated ALS. [PDF]
Argueti-Ostrovsky S +22 more
europepmc +1 more source
A new therapeutic approach to <i>KRAS</i> mutant non-small cell lung cancer: the emerging role of exportin 1 inhibition. [PDF]
von Itzstein MS, Gerber DE.
europepmc +1 more source
Erratum: <i>KRAS</i> under attack: recent advances in targeted therapies involving G12C inhibitors and XPO1 inhibition. [PDF]
Editorial Office.
europepmc +1 more source
Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency. [PDF]
Barajas JM +27 more
europepmc +1 more source
Combination effect of Exportin 1 inhibitor (KPT-335) with doxorubicin or vincristine in canine lymphoma cell lines. [PDF]
Primarizky H +4 more
europepmc +1 more source
Dual epigenetic and nuclear export inhibition by chidamide and selinexor in high grade B-cell lymphomas via survivin and PI3K/AKT inhibition. [PDF]
Lin J +9 more
europepmc +1 more source
Exportin 1 (XPO1; CRM1); histone deacetylase 1 (HDAC1) [PDF]
openaire +1 more source
Efficacy and safety of Ruxolitinib-based combination therapy in the patients with Myelofibrosis (MF): a systematic review and meta-analysis. [PDF]
Tan S, Li Y, Cao Y, Sun W, Hui W.
europepmc +1 more source

